Celltrion
068270.KS
HK$879.57
Share price
-1.89%
Change (1 day)
-14.74%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): HK$23.44
According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$23.18. In 2022 the company made an earnings per share (EPS) of HK$22.57 a decrease over its 2021 EPS that were of HK$26.81.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | HK$23.44 | 3.88% |
| 2022 | HK$22.57 | -15.84% |
| 2021 | HK$26.81 | 12.77% |
| 2020 | HK$23.78 | 70.79% |
| 2019 | HK$13.92 | 15.63% |
| 2018 | HK$12.04 | -33.13% |
| 2017 | HK$18.01 | 141.17% |
| 2016 | HK$7.47 | 8.28% |
| 2015 | HK$6.90 | 11.28% |
| 2014 | HK$6.20 | 16.37% |
| 2013 | HK$5.32 | -67.42% |
| 2012 | HK$16.35 | 84.22% |
| 2011 | HK$8.87 | 62.13% |
| 2010 | HK$5.47 | 80.61% |
| 2009 | HK$3.03 | -559.63% |
| 2008 | -HK$0.66 | -123.16% |
| 2007 | HK$2.85 |